Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

SHI Jing, ZHAO Min, XIE Wei-xing, YU Li-xin, YUAN Hui-ying. Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure[J]. Journal of Pharmaceutical Practice and Service, 2007, (5): 297-299.
Citation: SHI Jing, ZHAO Min, XIE Wei-xing, YU Li-xin, YUAN Hui-ying. Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure[J]. Journal of Pharmaceutical Practice and Service, 2007, (5): 297-299.

Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure

  • Received Date: 2006-03-23
  • Objective :To evaluate the clinical efficacy between urapidil and other vasodilators in acute left heart failure. Methods : 80 patients with acute left heart failure were randomly divided into 4 groups: urapidil group(n=19),phentolamine group(n=21),sodium nitroprusside group(n=16),nitroglycerin group(n=24).The change of dyspneic respiration,heart rate,blood preasure,and lung rales were recorded respectively in the process of the treatment. Results :Remission rate of dyspnea were 94.7% and 93.8% in urapidil group and sodium nitroprusside group respectively(P>0.05),nitroglycerin group was 47.7%(P<0.01).Incidence of heart rate acceleration were 66.7% and 5.3% in phentolamine group and urapidil group respectively(P<0.01).Incidence of blood pressure lowering and hypotension were 31.3% and 5.3% in sodium nitroprusside group and urapidil group respectively(P<0.05).Effective rate of reducing lung rales were 94.7% and 95.2% respectively(P>0.05),nitroglycerin group was 58.3%(P<0.05). Conclusion :The result proved that urapidil could be used as first aid for patients with acute left heart failure.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2103) PDF downloads(29) Cited by()

Related
Proportional views

Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure

Abstract: Objective :To evaluate the clinical efficacy between urapidil and other vasodilators in acute left heart failure. Methods : 80 patients with acute left heart failure were randomly divided into 4 groups: urapidil group(n=19),phentolamine group(n=21),sodium nitroprusside group(n=16),nitroglycerin group(n=24).The change of dyspneic respiration,heart rate,blood preasure,and lung rales were recorded respectively in the process of the treatment. Results :Remission rate of dyspnea were 94.7% and 93.8% in urapidil group and sodium nitroprusside group respectively(P>0.05),nitroglycerin group was 47.7%(P<0.01).Incidence of heart rate acceleration were 66.7% and 5.3% in phentolamine group and urapidil group respectively(P<0.01).Incidence of blood pressure lowering and hypotension were 31.3% and 5.3% in sodium nitroprusside group and urapidil group respectively(P<0.05).Effective rate of reducing lung rales were 94.7% and 95.2% respectively(P>0.05),nitroglycerin group was 58.3%(P<0.05). Conclusion :The result proved that urapidil could be used as first aid for patients with acute left heart failure.

SHI Jing, ZHAO Min, XIE Wei-xing, YU Li-xin, YUAN Hui-ying. Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure[J]. Journal of Pharmaceutical Practice and Service, 2007, (5): 297-299.
Citation: SHI Jing, ZHAO Min, XIE Wei-xing, YU Li-xin, YUAN Hui-ying. Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure[J]. Journal of Pharmaceutical Practice and Service, 2007, (5): 297-299.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return